Cover
Cover | May 07, 2020 |
Document Information [Line Items] | |
Document Type | 8-K |
Document Period End Date | May 7, 2020 |
Entity Registrant Name | XERIS PHARMACEUTICALS, INC. |
Entity Incorporation, State or Country Code | DE |
Entity File Number | 001-38536 |
Entity Tax Identification Number | 20-3352427 |
Entity Address, Address Line One | 180 N. LaSalle Street, |
Entity Address, Address Line Two | Suite 1600 |
Entity Address, City or Town | Chicago |
Entity Address, State or Province | IL |
Entity Address, Postal Zip Code | 60601 |
City Area Code | 844 |
Local Phone Number | 445-5704 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | Common Stock, par value $0.0001 per share |
Trading Symbol | XERS |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | true |
Entity Ex Transition Period | false |
Amendment Flag | false |
Entity Central Index Key | 0001346302 |